| 期 |
栏目 |
标题 |
文件 |
| 卷 10, 编号 2 (2013) |
Articles |
Use of diuretics in hypertensive patients with metabolic disturbances |
|
| 卷 10, 编号 3 (2013) |
Articles |
Primenenie diuretikov u bol'nykh arterial'noy gipertoniey s metabolicheskimi narusheniyami |
|
| 卷 10, 编号 4 (2013) |
Articles |
The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District |
|
| 卷 10, 编号 3 (2013) |
Articles |
Izuchenie kognitivnykh funktsiy mozga u bol'nykh arterial'noy gipertoniey s nalichiem ili otsutstviem metabolicheskogo sindroma |
|
| 卷 10, 编号 4 (2013) |
Articles |
Coagulogic risk factors of heart disease in the adult population of Tomsk |
|
| 卷 11, 编号 1 (2014) |
Articles |
Hypertension treatment features in perimenopausal women |
(Rus)
|
| 卷 11, 编号 1 (2014) |
Articles |
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components |
(Rus)
|
| 卷 11, 编号 2 (2014) |
Articles |
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
The state of the vascular wall in adult population of Tomsk in the framework of the project ESSAY RF |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
Calcium channel blockers: more than 50 years on guard of health |
(Rus)
|
| 卷 12, 编号 1 (2015) |
Articles |
The role of beta-blockers in the treatment of arterial hypertension: what do we know today |
(Rus)
|
| 卷 12, 编号 3 (2015) |
Articles |
Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension |
(Rus)
|
| 卷 12, 编号 3 (2015) |
Articles |
The prevalence of renal dysfunction in arterial hypertension (in the framework of the ESSE-RF study) |
(Rus)
|
| 卷 12, 编号 1 (2015) |
Articles |
Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach |
(Rus)
|
| 卷 14, 编号 3 (2017) |
Articles |
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders |
(Rus)
|
| 卷 15, 编号 1 (2018) |
Articles |
The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results |
(Rus)
|
| 卷 15, 编号 3 (2018) |
Articles |
Obesity as a predictor for cardiovascular disease development: role of localized fat depot |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Polypill" conception in modern cardiology |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Epicardial fat: a new cardiometabolic risk marker, a new therapeutic goal in obese patients |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity |
(Rus)
|
| 卷 16, 编号 4 (2019) |
Articles |
Consensus on patients with hyperuricemia and high cardiovascular risk treatment |
(Rus)
|
| 卷 16, 编号 3 (2019) |
Articles |
The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus |
(Rus)
|
| 卷 16, 编号 2 (2019) |
Articles |
Possibilities of blood pressure and metabolic disorders correction by using diet programs in patients with overweight and obesity |
(Rus)
|
| 卷 16, 编号 4 (2019) |
Articles |
Vascular wall status and its link with perivascular adipose tissue and other fat depots in young patients with abdominal obesity |
(Rus)
|
| 卷 17, 编号 2 (2020) |
Review |
COVID-19: a patient with cardiovascular disease at high risk |
(Rus)
|
| 卷 17, 编号 3 (2020) |
Expert opinion |
Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19 |
(Rus)
|
| 卷 17, 编号 3 (2020) |
Guidelines |
Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease |
(Rus)
|
| 卷 17, 编号 4 (2020) |
Articles |
Impact of metabolic syndrome parameters and different fat depots on arterial stiffness in patients with abdominal obesity |
(Rus)
|
| 卷 17, 编号 4 (2020) |
Articles |
Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus |
(Rus)
|
| 卷 17, 编号 4 (2020) |
Articles |
Assessment of epicardial adipose tissue by echocardiography for risk stratification in young adults with abdominal obesity |
(Rus)
|
| 卷 18, 编号 3 (2021) |
Expert opinion |
Management of patients with arterial hypertension and atrial fibrillation |
(Rus)
|
| 卷 18, 编号 3 (2021) |
Original Article |
Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders |
(Rus)
|
| 卷 18, 编号 4 (2021) |
Case Report |
Possibilities of a new glucagon-like peptide-1 receptor agonist Semaglutide in improving left ventricular diastolic function in a patient with arterial hypertension and type 2 diabetes mellitu |
(Rus)
|
